Top Institutions in Infectious Diseases / Tropical Medicine / Pediatric Pharmacology
Leading institutions in tropical medicine and pediatric infectious diseases have driven research on schistosomiasis, focusing on drug development, clinical trials, and public health implementation. Collaborative consortia involving pharmaceutical companies and global health institutes have been pivotal in advancing child-friendly formulations and treatment protocols.
-
#1
Swiss Tropical and Public Health Institute
Basel, Switzerland
A leading global center for tropical disease research and control, the institute has been instrumental in schistosomiasis research and was a founding member of the Pediatric Praziquantel Consortium, contributing to the development and evaluation of pediatric formulations.
Key Differentiators
- Tropical Medicine
- Infectious Diseases
- Public Health
-
#2
Astellas Pharma Inc.
Tokyo, Japan
Astellas led the pharmaceutical development of the child-friendly praziquantel formulation, overcoming significant technical challenges to create a product suitable for infants and toddlers, demonstrating strong pharmaceutical innovation and manufacturing expertise.
Key Differentiators
- Pharmaceutical Sciences
- Drug Development
- Pediatric Pharmacology
-
#3
London School of Hygiene & Tropical Medicine
London, United Kingdom
Renowned for its research in tropical diseases including schistosomiasis, LSHTM has contributed extensively to clinical trials, epidemiological studies, and public health strategies targeting schistosomiasis control and treatment in children.
Key Differentiators
- Tropical Medicine
- Epidemiology
- Global Health
-
#4
Centers for Disease Control and Prevention (CDC)
Atlanta, Georgia
CDC provides leadership in parasitic disease research and public health interventions, including schistosomiasis surveillance, treatment guidelines, and support for global health initiatives targeting pediatric populations.
Key Differentiators
- Infectious Diseases
- Public Health
- Parasitology
-
#5
Kenya Medical Research Institute (KEMRI)
Nairobi, Kenya
KEMRI is a leading African research institution conducting field-based schistosomiasis research and clinical trials, including studies on pediatric treatment efficacy and implementation of new drug formulations in endemic regions.
Key Differentiators
- Infectious Diseases
- Parasitology
- Clinical Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
